Head to head
AbbVie Inc. (ABBV)vsAlnylam Pharmaceuticals, Inc. (ALNY)
Price & valuation
| Metric | ABBV | ALNY |
|---|---|---|
| Price | $257.41 | $205.48 |
| Change | -2.24% | -28.31% |
| Market cap | — | — |
| P/E ratio | — | — |
| EPS | — | — |
| 52-week high | — | — |
| 52-week low | — | — |
| Volume | 6,398,916 | 9,753,222 |
Latest annual financials
| Metric | ABBV | ALNY |
|---|---|---|
| Revenue | $61.16B | $3.71B |
| Net income | $4.23B | -$18.25M |
| EPS | $2.36 | -$0.14 |